Goldman Sachs Downgrades 2Seventy Bio Inc. (TSVT) to Neutral, 'Monitoring execution on Abecma and the pipeline'
Tweet Send to a Friend
Goldman Sachs analyst Salveen Richter downgraded 2Seventy Bio Inc. (NASDAQ: TSVT) from Buy to Neutral with a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
